Financial Personal
ImmunoPrecise Antibodies to Reschedule Financial Results and Recent Business Highlights Report for Fourth Quarter and Fiscal Year-End 2024
The Company to host an earnings conference call via webcast VICTORIA, British Columbia — ImmunoPrecise Antibodies Ltd. (the “Company” or “IPA”) (NASDAQ: IPA) today announces the rescheduling of its full year fiscal 2024
VICTORIA, British Columbia -- ImmunoPrecise Antibodies Ltd. (the "Company" or "IPA") (NASDAQ: IPA) today announces the rescheduling of its full year fiscal 2024 financial results and business highlights release. Originally set for July 25, 2024, the new release date is Monday, July 29, 2024, and will hold an earnings call at 10:30 am Eastern Time the same day. Read More
Related
Share this page
Guest Posts by Easy BranchesGet Reliable Matka Guessing Forum with our Satta Matka Expert and Get all Matka Chart For Free.
